other

Updated:

Biosynthetic Technologies

Biosynthetic Technologies produces base oils using Estolides, a class of biobased synthetic compounds made from organic fatty acids found in bio-derived...

Biosynthetic Technologies

Biosynthetic Technologies produces base oils using Estolides, a class of biobased synthetic compounds made from organic fatty acids found in bio-derived oils. The company positions its products as sustainable replacements for petroleum-based lubricants and additives in industrial applications. The firm focuses on four market segments: industrial lubricants, metalworking fluids, grease, and personal care. Its BioEstolides line serves the beauty and personal care industry as certified vegan, Halal, Kosher, and REACH-registered emollients. Biosynthetic's oils are compatible with existing common base oils and additives, enabling drop-in substitution without reformulation. Recent news on the company's website highlights the appointment of Matthew Kriech as CEO. The firm operates from its Indianapolis headquarters and does not publicly disclose additional offices, team size, or financial metrics such as AUM or deployment. No ownership structure or family-office association has been publicly confirmed. Biosynthetic Technologies distinguishes itself by manufacturing Estolide-based base oils at commercial scale, a technology that offers oxidative, hydrolytic, thermal, and UV stability. The company's model is product-focused rather than investment-driven, making it an operating company rather than a traditional allocator or family office.

General information

Firm type

other

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Indianapolis

Corporate office

Indianapolis, IN, United States

Principals

Matthew Kriech

CEO

Sector focus

Industrial TechnologyEnergy Transition & RenewablesPersonal Care

Frequently asked questions

What does Biosynthetic Technologies produce?

Biosynthetic Technologies manufactures sustainable base oils and additives using Estolides, a biobased synthetic compound derived from organic fatty acids. Its products serve industrial lubricants, metalworking fluids, grease, and personal care markets (per the firm's website).

Who leads Biosynthetic Technologies?

Matthew Kriech serves as CEO, as announced on the company's website. Other executives and the board are not publicly disclosed.

Is Biosynthetic Technologies a family office?

No. Biosynthetic Technologies is an operating company that manufactures and sells base oils. No public information links it to a family office, wealth origin, or investment fund.

What are Estolides?

Estolides are a class of biobased synthetic compounds made from organic fatty acids found in various bio-derived oils. They can function as the primary base oil in lubricant formulations, as a component of a base oil co-blend, or as an additive (per the firm's website).

Which industries use Biosynthetic Technologies' products?

The company targets industrial lubricants (gear oils, grease, hydraulics, metalworking fluids), personal care (suncare, color cosmetics, haircare, skincare), and food-grade applications. Its oils are compatible with common existing formulations (per the firm's website).

Does Biosynthetic Technologies disclose financial metrics?

No. The company does not publish AUM, revenue, funding rounds, valuation, or deployment figures. Its ownership and capitalization are not publicly known.

Where is Biosynthetic Technologies headquartered?

The firm is based in Indianapolis, Indiana, United States. No additional office locations are disclosed.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo